04:27 PM EDT, 09/16/2024 (MT Newswires) -- Bicara Therapeutics ( BCAX ) said Monday it closed its initial public offering of more than 20.1 million shares at $18 apiece, with gross proceeds of about $362 million.

The company said the offering includes almost 2.63 million shares issued upon the exercise in full by the underwriters of their option to purchase additional shares. The company sold all the shares in the IPO.

Bicara's shares began trading on the Nasdaq Global Market on Friday under the "BCAX" ticker.

Shares of the company closed 8.5% higher on Monday.